<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02423642</url>
  </required_header>
  <id_info>
    <org_study_id>IRB.NO.136/56</org_study_id>
    <nct_id>NCT02423642</nct_id>
  </id_info>
  <brief_title>Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Continuous Renal Replacement Therapy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the effect of anticoagulation in immune response with
      Acute Kidney Injury (AKI) undergoing Continuous Renal Replacement Therapy (CRRT).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functions of inflammatory cells</measure>
    <time_frame>24 hours</time_frame>
    <description>CD11b expression on PMN and HLA-DR expression on monocyte</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Regulation of inflammatory reactions and and opsonization in microorganisms</measure>
    <time_frame>24 hours</time_frame>
    <description>C3a and C5a</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Activity of acute phase protein during acute inflammation</measure>
    <time_frame>24 hours</time_frame>
    <description>PAI-1</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>survival rate</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of ICU stay</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>AKI requring CRRT and use regional citrate anticoagulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CRRT use regional citrate anticoagulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AKI requring CRRT and not use regional citrate anticoagulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CRRT not use regional citrate anticoagulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous renal replacement therapy with regional citrate anticoagulation</intervention_name>
    <description>CRRT with anticoagulant : regional citrate anticoagulation
Filter : AQUAMAX™ (Edwards Lifesciences)</description>
    <arm_group_label>AKI requring CRRT and use regional citrate anticoagulation</arm_group_label>
    <other_name>Continuous veno-venous hemofiltration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous renal replacement therapy with no anticoagulation or heparin</intervention_name>
    <description>CRRT with any anticoagulant : no anticoagulation or heparin Filter : AQUAMAX™ (Edwards Lifesciences)</description>
    <arm_group_label>AKI requring CRRT and not use regional citrate anticoagulation</arm_group_label>
    <other_name>Continuous veno-venous hemofiltration</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Systemic inflammatory response syndrome; SIRS &gt; or = 2 meets definition

          -  Patients with acute kidney injury in the intensive care ward.

          -  Requiring continuous renal replacement therapy.

        Exclusion Criteria:

          -  Pregnancy

          -  Cirrhosis

          -  End stage renal disease

          -  HIV infection

          -  Serum creatinine in male &gt; 2 mg/dl and female &gt; 1.5 mg/dl

          -  Bleeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sasipha Tachaboon</name>
      <address>
        <city>Bangkok</city>
        <state>Pathumwan</state>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2015</study_first_submitted>
  <study_first_submitted_qc>April 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2015</study_first_posted>
  <last_update_submitted>April 19, 2015</last_update_submitted>
  <last_update_submitted_qc>April 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Nattachai Srisawat ,M.D.</investigator_full_name>
    <investigator_title>Division of Nephrology, Department of Medicine, Faculty of Medicine</investigator_title>
  </responsible_party>
  <keyword>Acute Kidney Injury Requiring Continuous Renal Replacement Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

